Fortress Biotech Inc FBIO:NASDAQ

Last Price$0.86NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/13/22

Today's Change+0.06(7.29%)
Bid (Size)$0.90 (11)
Ask (Size)$0.95 (1)
Day Low / High$0.83 - 0.97
Volume695.7 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 05/13/2022


Fortress Biotech Inc ( NASDAQ )

Price: $0.86
Change: +0.06 (7.29%)
Volume: 695.7 K
4:00PM ET 5/13/2022


Price: $0.40
Change: +0.009 (2.33%)
Volume: 1.2 M
4:00PM ET 5/13/2022

TCR2 Therapeutics Inc ( NASDAQ )

Price: $2.35
Change: -0.01 (0.42%)
Volume: 405.6 K
4:00PM ET 5/13/2022

Ardelyx Inc ( NASDAQ )

Price: $0.65
Change: +0.009 (1.44%)
Volume: 2.2 M
4:00PM ET 5/13/2022

Dare Bioscience Inc ( NASDAQ )

Price: $1.05
Change: +0.02 (1.94%)
Volume: 781.7 K
4:00PM ET 5/13/2022

Read more news Recent News

-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q1 Revenue $23.9M, vs. Street Est of $20.7M
4:04PM ET 5/12/2022 MT Newswires


-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q1 Loss $-0.10, vs. Street Est of EPS $0.01
4:03PM ET 5/12/2022 MT Newswires


--Benchmark Capital Adjusts Fortress Biotech's Price Target to $5 from $8, Keeps Buy Rating
11:34AM ET 3/29/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Fortress Biotech Starts Mid-Stage Triplex Vaccine Trial in Adults with HIV, Cytomegalovirus
10:56AM ET 12/16/2021 MT Newswires

Fortress Biotech (FBIO) on Thursday said that it has commenced a phase 2 trial to evaluate the safety, efficacy, and immunogenicity of Triplex in eliciting...

View all Commentary and Analysis

Stocks To Watch: Retail Heavyweights Report, Block And Moderna Events
9:27AM ET 5/14/2022 Seeking Alpha

Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates
4:35PM ET 5/12/2022 Zacks

Fortress Biotech (FBIO) delivered earnings and revenue surprises of 35.71% and 19.27%,...

Fortress Biotech (FBIO) Investor Presentation - Slideshow
5:54AM ET 4/06/2022 Seeking Alpha

Fortress Biotech (FBIO) Investor Presentation - Slideshow
6:42AM ET 3/20/2022 Seeking Alpha

Company Profile

Business DescriptionFortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL. View company web site for more details
Address1111 Kane Concourse
Bay Harbor Islands, Florida 33154
Number of Employees88
Recent SEC Filing05/12/202210-Q
Chairman, President & Chief Executive OfficerLindsay Allan Rosenwald
Chief Financial Officer, Secretary & TreasurerRobyn M. Hunter
Senior Vice President-Biologics OperationsGeorge C. Avgerinos
Director & Vice Chairman-Strategic DevelopmentMichael Sean Weiss

Company Highlights

Price Open$0.83
Previous Close$0.80
52 Week Range$0.79 - 4.49
Market Capitalization$92.2 M
Shares Outstanding107.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/15/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.02
Beta vs. S&P 500N/A
Revenue$26.9 M
Net Profit Margin-94.06%
Return on Equity-62.29%

Analyst Ratings as of 02/25/2021

Consensus RecommendationConsensus Icon
Powered by Factset